- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
September 1st, 2008
Tata Industries is planning to invest Rs 800-1,000 crore in biotechnology and nanotechnology. The company has already pum-ped in Rs 125 crore in these segments, Mr Kishor Chau-kar, managing director, said.
"Contract research, drug discovery and herbal medicine are areas that are at the top of our priority list. We are trying to come up with a drug for fighting diabetes and metabolic disorders," Mr Chaukar said. Tata Industries has invested Rs 80 crore in three entities in this segment, of which, Indigene, has operations in Hyderabad.
He said, "We are interested in a bio warfare project that is being developed by a non-resident Indian scientist in association with the US defence department. We think the project has great potential even in the field of medicine and hence have put in Rs 60 crore in the technology." If successful, the company would buy the rights to the technology and launch it in India, Africa and Latin America, he added.
|Related News Press|
News and information
Harris & Harris Group Sponsors NYC American Heart Association's Health Sciences Innovation Investment Forum: Co-founder of Harris & Harris Group Portfolio Company TARA Biosystems to Speak About the Value of Tissue Engineering Technology April 21st, 2015
Long Island Capital Alliance Announces Participants for Brookhaven National Laboratory Technology Transfer Capital Forum on May 8: Keynote Speaker Dr. Doon Gibbs, Director of Brookhaven National Laboratory April 16th, 2015
Graphenea embarks on a new era April 16th, 2015
Graphenea celebrates fifth anniversary April 27th, 2015
Two-dimensional semiconductor comes clean April 27th, 2015
Electron spin brings order to high entropy alloys April 23rd, 2015
Engineer improves rechargeable batteries with MoS2 nano 'sandwich' April 18th, 2015